Androgen-like and anti-androgen-like effects of antiprogestins in human mammary cancer cells

This publication has 19 references indexed in Scilit:

• Estrogenic effects of the antiprogestin onapristone (ZK98.299) in the rodent uterus
  American Journal of Obstetrics and Gynecology, 1994
• Androgen responsiveness of the new human endometrial cancer cell line MFE‐296
  International Journal of Cancer, 1994
• Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor
  Breast Cancer Research and Treatment, 1993
• An Improved CAT Assay for Promoter Analysis in Either Transgenic Mice or Tissue Culture Cells
  DNA and Cell Biology, 1992
• Down-regulation of androgen receptor by progestins and interference with estrogenic or androgenic stimulation of mammary carcinoma cell growth
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1990
• Antigestagene
  Geburtshilfe und Frauenheilkunde, 1988
• Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line
  Breast Cancer Research and Treatment, 1988
• Difference between R5020 and the antiprogestin RU486 in antiproliferative effects on human breast cancer cells
  Breast Cancer Research and Treatment, 1987
• Studies on the mechanisms of action of progesterone antagonists
  Journal of Steroid Biochemistry, 1986
• Onset of androgen action in MCF-7 human breast cancer cells is not accompanied by receptor depletion
  The Journal of Steroid Biochemistry and Molecular Biology, 1985